[HTML][HTML] Advancements in the Development of Anti-SARS-CoV-2 Therapeutics
J Huang, Q Ma, Z Su, X Cheng - International Journal of Molecular …, 2024 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes
COVID-19, and so far, it has occurred five noteworthy variants of concern (VOC). SARS-CoV …
COVID-19, and so far, it has occurred five noteworthy variants of concern (VOC). SARS-CoV …
Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern
Glycosylation of the SARS-CoV-2 spike (S) protein represents a key target for viral evolution
because it affects both viral evasion and fitness. Successful variations in the glycan shield …
because it affects both viral evasion and fitness. Successful variations in the glycan shield …
Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals
E Galeota, V Bevilacqua, A Gobbini, P Gruarin… - Clinical …, 2024 - Elsevier
Multiple vaccines have been approved to control COVID-19 pandemic, with Pfizer/BioNTech
(BNT162b2) being widely used. We conducted a longitudinal analysis of the immune …
(BNT162b2) being widely used. We conducted a longitudinal analysis of the immune …
Development of a two-component recombinant vaccine for COVID-19
YS Sun, F Xu, HP Zhu, Y Xia, QM Li, YY Luo… - Frontiers in …, 2024 - frontiersin.org
Introduction Though COVID-19 as a public health emergency of international concern
(PHEIC) was declared to be ended by the WHO, it continues to pose a significant threat to …
(PHEIC) was declared to be ended by the WHO, it continues to pose a significant threat to …
1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit
J Nahalka - International Journal of Molecular Sciences, 2024 - mdpi.com
The COVID-19 pandemic prompted rapid research on SARS-CoV-2 pathogenicity.
Consequently, new data can be used to advance the molecular understanding of SARS …
Consequently, new data can be used to advance the molecular understanding of SARS …
[HTML][HTML] Beta Spike-Presenting SARS-CoV-2 Virus-like Particle Vaccine Confers Broad Protection against Other VOCs in Mice
Virus-like particles (VLPs) are non-infectious and serve as promising vaccine platforms
because they mimic the membrane-embedded conformations of fusion glycoproteins on …
because they mimic the membrane-embedded conformations of fusion glycoproteins on …
[HTML][HTML] Leveraging Walnut Somatic Embryos as a Biomanufacturing Platform for Recombinant Proteins and Metabolites
Biomanufacturing enables novel sources of compounds with constant demand, such as food
coloring and preservatives, as well as new compounds with peak demand, such as …
coloring and preservatives, as well as new compounds with peak demand, such as …
[HTML][HTML] Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac
DA Díaz-Dinamarca, S Cárdenas-Cáceres, NA Muena… - Vaccines, 2024 - mdpi.com
The SARS-CoV-2 Omicron variant and its sublineages continue to cause COVID-19-
associated pediatric hospitalizations, severe disease, and death globally. BNT162b2 and …
associated pediatric hospitalizations, severe disease, and death globally. BNT162b2 and …
Generación de un método de selección clonal específico de antígeno y su aplicación para la identificación de anticuerpos monoclonales contra el SARS-CoV-2
RQ MANZANARES - 2023 - riaa.uaem.mx
El sistema inmune tiene la capacidad de responder a una amplia variedad de antígenos al
generar un amplio repertorio de receptores de células B (BCR). Sin embargo, la generación …
generar un amplio repertorio de receptores de células B (BCR). Sin embargo, la generación …